What is Epitopea?
Founded in 2021, Epitopea is a dynamic player in the medtech sector, dedicated to developing novel approaches to cancer treatment. Operating from the vibrant innovation hub of Cambridge, United Kingdom, the company leverages cutting-edge research and development to address unmet needs in oncology. Its focus on innovative therapies positions it as a key emerging entity within the competitive landscape of cancer care solutions.
How much funding has Epitopea raised?
Epitopea has raised a total of $31.6M across 2 funding rounds:
Other Financing Round
$650K
Other Financing Round
$31M
Other Financing Round (2022): $650K with participation from Defi Research Institute, Matters, and Smart-Chain
Other Financing Round (2024): $31M led by Advent Life Sciences, Cambridge Innovation Capital, and Investissement Quebec
Key Investors in Epitopea
Advent Life Sciences
Advent Life Sciences is a venture capital firm specializing in early and mid-stage life sciences investments, with a focus on developing innovative medicines and medical products. They actively partner with management teams to bring breakthrough science to market.
Cambridge Innovation Capital
Cambridge Innovation Capital is a venture investor supporting entrepreneurs in life sciences and deep tech within the Cambridge ecosystem, providing financial backing and expert guidance to innovative start-ups.
Investissement Quebec
Investissement Quebec is a provincial Crown corporation dedicated to assisting in the growth of investment in Quebec, contributing to economic development and job creation through a range of financial solutions.
What's next for Epitopea?
With substantial backing from prominent investors, Epitopea is poised for accelerated growth and the expansion of its therapeutic pipeline. The recent major strategic investment suggests a focus on advancing its technology through clinical trials and potential commercialization phases. This infusion of capital will likely fuel further research, talent acquisition, and the scaling of its operational infrastructure, reinforcing its commitment to making a significant impact in cancer treatment.
See full Epitopea company page
